Literature DB >> 19451633

Proteomic screening of variola virus reveals a unique NF-kappaB inhibitor that is highly conserved among pathogenic orthopoxviruses.

Mohamed R Mohamed1, Masmudur M Rahman, Jerry S Lanchbury, Donna Shattuck, Chris Neff, Max Dufford, Nick van Buuren, Katharine Fagan, Michele Barry, Scott Smith, Inger Damon, Grant McFadden.   

Abstract

Identification of the binary interactions between viral and host proteins has become a valuable tool for investigating viral tropism and pathogenesis. Here, we present the first systematic protein interaction screening of the unique variola virus proteome by using yeast 2-hybrid screening against a variety of human cDNA libraries. Several protein-protein interactions were identified, including an interaction between variola G1R, an ankryin/F-box containing protein, and human nuclear factor kappa-B1 (NF-kappaB1)/p105. This represents the first direct interaction between a pathogen-encoded protein and NF-kappaB1/p105. Orthologs of G1R are present in a variety of pathogenic orthopoxviruses, but not in vaccinia virus, and expression of any one of these viral proteins blocks NF-kappaB signaling in human cells. Thus, proteomic screening of variola virus has the potential to uncover modulators of the human innate antiviral responses.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19451633      PMCID: PMC2683884          DOI: 10.1073/pnas.0900452106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  48 in total

Review 1.  Evasion of innate immunity by vaccinia virus.

Authors:  I R Haga; A G Bowie
Journal:  Parasitology       Date:  2005       Impact factor: 3.234

Review 2.  The ubiquitin system for protein degradation and some of its roles in the control of the cell-division cycle (Nobel lecture).

Authors:  Avram Hershko
Journal:  Angew Chem Int Ed Engl       Date:  2005-09-19       Impact factor: 15.336

Review 3.  An arms race: innate antiviral responses and counteracting viral strategies.

Authors:  M Schröder; A G Bowie
Journal:  Biochem Soc Trans       Date:  2007-12       Impact factor: 5.407

4.  Quantification of cAMP antagonist action in vitro and in living cells.

Authors:  Frank Gesellchen; Anke Prinz; Bastian Zimmermann; Friedrich W Herberg
Journal:  Eur J Cell Biol       Date:  2006-03-10       Impact factor: 4.492

5.  Poxviral regulation of the host NF-kappaB response: the vaccinia virus M2L protein inhibits induction of NF-kappaB activation via an ERK2 pathway in virus-infected human embryonic kidney cells.

Authors:  Roderick Gedey; Xiao-Lu Jin; Olivia Hinthong; Joanna L Shisler
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

6.  Myxoma virus M063R is a host range gene essential for virus replication in rabbit cells.

Authors:  John W Barrett; Chew Shun Chang; Gen Wang; Steven J Werden; Zhuhong Shao; Catherine Barrett; Xiujuan Gao; Tara A Belsito; Danielle Villenevue; Grant McFadden
Journal:  Virology       Date:  2006-12-20       Impact factor: 3.616

7.  Polo-like kinase 3 is required for entry into S phase.

Authors:  Wendy C Zimmerman; Raymond L Erikson
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-30       Impact factor: 11.205

Review 8.  Viral regulation and evasion of the host response.

Authors:  Y M Loo; M Gale
Journal:  Curr Top Microbiol Immunol       Date:  2007       Impact factor: 4.291

9.  New insights into the subversion of the chemokine system by poxviruses.

Authors:  Antonio Alcami
Journal:  Eur J Immunol       Date:  2007-04       Impact factor: 5.532

10.  A chemokine-binding domain in the tumor necrosis factor receptor from variola (smallpox) virus.

Authors:  Alí Alejo; M Begoña Ruiz-Argüello; Yin Ho; Vincent P Smith; Margarida Saraiva; Antonio Alcami
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-31       Impact factor: 12.779

View more
  34 in total

Review 1.  Poxvirus proteomics and virus-host protein interactions.

Authors:  Kim Van Vliet; Mohamed R Mohamed; Leiliang Zhang; Nancy Yaneth Villa; Steven J Werden; Jia Liu; Grant McFadden
Journal:  Microbiol Mol Biol Rev       Date:  2009-12       Impact factor: 11.056

2.  Recombinant myxoma virus lacking all poxvirus ankyrin-repeat proteins stimulates multiple cellular anti-viral pathways and exhibits a severe decrease in virulence.

Authors:  Stephanie A Lamb; Masmudur M Rahman; Grant McFadden
Journal:  Virology       Date:  2014-07-26       Impact factor: 3.616

Review 3.  A cell-free approach to accelerate the study of protein-protein interactions in vitro.

Authors:  E Sierecki; N Giles; M Polinkovsky; M Moustaqil; K Alexandrov; Y Gambin
Journal:  Interface Focus       Date:  2013-10-06       Impact factor: 3.906

4.  Ectromelia virus encodes a BTB/kelch protein, EVM150, that inhibits NF-κB signaling.

Authors:  Qian Wang; Kristin Burles; Brianne Couturier; Crystal M H Randall; Joanna Shisler; Michele Barry
Journal:  J Virol       Date:  2014-02-12       Impact factor: 5.103

5.  Poxviruses as Gene Therapy Vectors: Generating Poxviral Vectors Expressing Therapeutic Transgenes.

Authors:  Steven J Conrad; Jia Liu
Journal:  Methods Mol Biol       Date:  2019

6.  Genetic screen of a mutant poxvirus library identifies an ankyrin repeat protein involved in blocking induction of avian type I interferon.

Authors:  Stephen M Laidlaw; Rebecca Robey; Marc Davies; Efstathios S Giotis; Craig Ross; Karen Buttigieg; Stephen Goodbourn; Michael A Skinner
Journal:  J Virol       Date:  2013-02-20       Impact factor: 5.103

7.  Genetic screen of a library of chimeric poxviruses identifies an ankyrin repeat protein involved in resistance to the avian type I interferon response.

Authors:  Karen Buttigieg; Stephen M Laidlaw; Craig Ross; Marc Davies; Stephen Goodbourn; Michael A Skinner
Journal:  J Virol       Date:  2013-02-20       Impact factor: 5.103

Review 8.  Killing a killer: what next for smallpox?

Authors:  Grant McFadden
Journal:  PLoS Pathog       Date:  2010-01-29       Impact factor: 6.823

9.  Co-regulation of NF-kappaB and inflammasome-mediated inflammatory responses by myxoma virus pyrin domain-containing protein M013.

Authors:  Masmudur M Rahman; Mohamed R Mohamed; Manbok Kim; Sherin Smallwood; Grant McFadden
Journal:  PLoS Pathog       Date:  2009-10-23       Impact factor: 6.823

10.  Analysis of vaccinia virus-host protein-protein interactions: validations of yeast two-hybrid screenings.

Authors:  Leiliang Zhang; Nancy Y Villa; Masmudur M Rahman; Sherin Smallwood; Donna Shattuck; Chris Neff; Max Dufford; Jerry S Lanchbury; Joshua Labaer; Grant McFadden
Journal:  J Proteome Res       Date:  2009-09       Impact factor: 4.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.